Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

Pharmaceutical Manufacturing 45

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 45

Pharmaceutical Technology

MAY 23, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 1,948 in Q1 2023, versus 2,528 in the prior quarter.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

pharmaphorum

DECEMBER 28, 2022

So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness? Any purchasing company would ideally like to integrate their acquisitions into their company seamlessly.

Pharmaceutical Manufacturing 110

Pharmaceutical Manufacturing Documentation Pharmaceutical Companies Pharmaceutical Companies 110

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 Other contributing factors include the decreasing number of post-market studies and difficulties in primary research and manufacturing.

Drug Pricing 69

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 69

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Nursing Homes 97

Nursing Homes Pharmaceutical Manufacturing Department of Veterans Affairs Dosage 97

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Green Chemistry in the Synthesis of Pharmaceuticals.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

European Pharmaceutical Review

AUGUST 17, 2022

We are the largest life sciences coalition bringing together various life science industry representatives,” including over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations, to drive collaborative approaches and measure the life-sciences’ industry progress to curb AMR. 2022; DOI: [link].

Hospitals 98

Hospitals Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 Other contributing factors include the decreasing number of post-market studies and difficulties in primary research and manufacturing.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

European Pharmaceutical Review

OCTOBER 20, 2022

Annex 1 states that “at least one representative sample is included every day that the water is used for manufacturing processes” Another important aspect of grab sampling is the frequency, which is up to the pharmaceutical company to determine. Inspection Technical Guide – Water for Pharmaceutical Use.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 98

pharmaphorum

DECEMBER 16, 2022

Achium outlined that, as of June 2022, over 72% of people in high-income countries had been vaccinated with at least one dose of a COVID-19 vaccine, while only 17% of people in low-income countries could say the same. The discussions over the treaty are set to continue for some time.

Vaccines 78

Vaccines Pharmaceutical Manufacturing Labelling Compounding 78

pharmaphorum

OCTOBER 27, 2022

The Guidance applies to all member companies of EFPIA and IFPMA, but also acts as useful guidance for all pharmaceutical companies as to how the authorities will interpret the legislative provisions to social media channels. The Guidance applies to both product-related and therapeutic-area-related activities.

Communication 87

Communication Pharmaceutical Manufacturing Packaging Documentation 87

Quality Matters

SEPTEMBER 15, 2023

PCM not ideal for every drug Continuous manufacturing “may not be fit for every pharmaceutical manufacturing process, but it can bring some advantages in some cases” compared with traditional batch manufacturing, summarized FDA’s Adam Fisher, Ph.D.,

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Dosage 52

PharmaShots

FEBRUARY 27, 2023

The speakers shared their views on the topic: Dr. Jagadeesh Babu Rangisetty- “COVID has taught us so many things and the pharmaceutical company has gone through a lot of challenges and at the same time opportunities. According to me the main issue faced during the pandemic was the supply chain of pharmaceuticals.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. Despite having large biopharmaceutical companies on home ground, the UK and France experienced major shortages and supply chain issues.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

DECEMBER 19, 2022

in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. Companies relying on angel investors and venture capitalists will be most affected by an economic downturn.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69

Pharmaceutical Technology

FEBRUARY 9, 2023

Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.

Packaging 52

Packaging Pharmaceutical Manufacturing Communication Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52